This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Imai E (2011) Guidelines for the treatment of nephrotic syndrome. Nihon Jinzou Gakkai Shi 53(2):78–122
Muso E, Mune M, Yorioka N, Nishizawa Y, Hirano T, Hattori M, Sugiyama S, Watanabe T, Kimura K, Yokoyama H, Sato H, Saito T (2007) Beneficial effect of low-density lipoprotein apheresis (LDL-A) on refractory nephrotic syndrome (NS) due to focal glomerulosclerosis (FGS). Clinical nephrology 67(6):341–344
Muso E, Saito T (2013 Abstract) Comparison of the clinical efficacy of LDL apheresis for the drug resistant nephrotic syndrome caused by focal segmental glomerulosclerosis (FGS) and non FGS in the POLARIS study. The World Congress of Nephrology 2013 abstract SA246 http://www.abstracts2view.com/wcn/view.php?nu=WCN13L_977
Hattori M, Chikamoto H, Akioka Y, Nakakura H, Ogino D, Matsunaga A, Fukazawa A, Miyakawa S, Khono M, Kawaguchi H, Ito K (2003) A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children. Am J Kidney Dis (the official journal of the National Kidney Foundation) 42(6):1121–1130
Nakamura T, Kawagoe Y, Ogawa H, Ueda Y, Hara M, Shimada N, Ebihara I, Koide H (2005) Effect of low-density lipoprotein apheresis on urinary protein and podocyte excretion in patients with nephrotic syndrome due to diabetic nephropathy. Am J Kidney Dis (the official journal of the National Kidney Foundation) 45(1):48–53
Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nature medicine 17(8):952–960. doi:10.1038/nm.2411
Koyama A, Yamagata K, Makino H, Arimura Y, Wada T, Nitta K, Nihei H, Muso E, Taguma Y, Shigematsu H, Sakai H, Tomino Y, Matsuo S, Japan RRG (2009) A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clinical and experimental nephrology 13(6):633–650. doi:10.1007/s10157-009-0201-7
Levy JB, Turner AN, Rees AJ, Pusey CD (2001) Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Annals of internal medicine 134(11):1033–1042
Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, Mirapeix E, Savage CO, Sinico RA, Stegeman CA, Westman KW, van der Woude FJ, de Lind van Wijngaarden RA, Pusey CD, European Vasculitis Study G (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18 (7):2180–2188. doi: 10.1681/ASN.2007010090
Walsh M, Casian A, Flossmann O, Westman K, Höglund P, Pusey C, Jayne DR (2013) Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear. Kidney International advance online publication 24 April 2013 doi: 10.1038/ki.2013.131
Walsh M, Catapano F, Szpirt W, Thorlund K, Bruchfeld A, Guillevin L, Haubitz M, Merkel PA, Peh CA, Pusey C, Jayne D (2011) Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis. Am J Kidney Dis (the official journal of the National Kidney Foundation) 57(4):566–574. doi:10.1053/j.ajkd.2010.10.049
Hasegawa M, Nishii C, Kabutan N, Kato M, Ohashi A, Nakai S, Murakami K, Tomita M, Nabeshima K, Hiki Y, Oshima H, Sugiyama S (2007) Effects of cytapheresis on tumor necrosis factor receptor and on expression of CD63 in myeloperoxidase–antineutrophil cytoplasmic autoantibody-associated vasculitis. Ther Apher Dial (official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy) 11(5):337–340. doi:10.1111/j.1744-9987.2007.00496.x
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Japan
About this chapter
Cite this chapter
Iwagami, M., Negishi, K. (2014). Kidney Diseases. In: Noiri, E., Hanafusa, N. (eds) The Concise Manual of Apheresis Therapy. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54412-8_25
Download citation
DOI: https://doi.org/10.1007/978-4-431-54412-8_25
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54411-1
Online ISBN: 978-4-431-54412-8
eBook Packages: MedicineMedicine (R0)